Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The history shows an added Revision: v3.4.2 and deletions of a funding notice and Revision: v3.4.1; these are administrative site maintenance changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T09:29:30.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:18:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now includes a 'Show glossary' option and notes explaining the color-coded changes (green and red highlights). The revision metadata was updated to v3.4.0 and the No FEAR Act data item was removed.
    Difference
    0.6%
    Check dated 2026-01-28T04:25:34.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 to the history and removed Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:11:29.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a new site revision entry, Revision: v3.3.3, to the history and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T09:09:22.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page header now displays Revision: v3.3.2, replacing Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T17:07:51.000Z thumbnail image

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.